Jim Simons's position in Biogen is currently worth $141 Million. That's 0.22% of their equity portfolio (96th largest holding). The first Biogen trade was made in Q2 2013. Since then Jim Simons bought shares nineteen more times and sold shares on 27 occasions. The investor's estimated purchase price is $308 Million, resulting in a loss of 54%.